Literature DB >> 7536300

Sickle cell anemia--basic research reaches the clinic.

A N Schechter, G P Rodgers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7536300     DOI： 10.1056/NEJM199505183322010

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Comparison of radial immunodiffusion and alkaline cellulose acetate electrophoresis for quantitating elevated levels of fetal hemoglobin (HbF): application to evaluating patients with sickle cell disease treated with hydroxyurea.

Authors:  J C Schultz
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

Review 2.  Sickle cell disease expenditures and outcomes.

Authors:  A N Schechter
Journal:  Public Health Rep       Date:  1997 Jan-Feb       Impact factor: 2.792

3.  Limbal stem cell deficiency arising from systemic chemotherapy with hydroxycarbamide.

Authors:  Xiaoyan Ding; Rachel J Bishop; Alexandra A Herzlich; Mrinali Patel; Chi-Chao Chan
Journal:  Cornea       Date:  2009-02       Impact factor: 2.651

4.  Nitric oxide generation from hydroxyurea via copper-catalyzed peroxidation and implications for pharmacological actions of hydroxyurea.

Authors:  K Sato; T Akaike; T Sawa; Y Miyamoto; M Suga; M Ando; H Maeda
Journal:  Jpn J Cancer Res       Date:  1997-12

5.  Effectiveness and Safety of Hydroxyurea in the Treatment of Sickle Cell Anaemia Children in Jos, North Central Nigeria.

Authors:  Akinyemi O D Ofakunrin; Stephen Oguche; Kehinde Adekola; Edache S Okpe; Tolulope O Afolaranmi; Ijeoma N Diaku-Akinwumi; Ayuba I Zoakah; Atiene S Sagay
Journal:  J Trop Pediatr       Date:  2020-06-01       Impact factor: 1.165

6.  The influence of hydroxyurea on oxidative stress in sickle cell anemia.

Authors:  Lidiane de Souza Torres; Danilo Grünig Humberto da Silva; Edis Belini Junior; Eduardo Alves de Almeida; Clarisse Lopes de Castro Lobo; Rodolfo Delfini Cançado; Milton Artur Ruiz; Claudia Regina Bonini-Domingos
Journal:  Rev Bras Hematol Hemoter       Date:  2012

7.  Hematological differences between patients with different subtypes of sickle cell disease on hydroxyurea treatment.

Authors:  Fabia Neves; Osvaldo Alves Menezes Neto; Larissa Bueno Polis; Sarah Cristina Bassi; Denise Menezes Brunetta; Ana Cristina Silva-Pinto; Ivan Lucena Angulo
Journal:  Rev Bras Hematol Hemoter       Date:  2012

8.  Comment on "The influence of hydroxyurea on oxidative stress in sickle cell anemia".

Authors:  Eduard Johannes van Beers; Gregory James Kato
Journal:  Rev Bras Hematol Hemoter       Date:  2012
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.